ABRILADA™ Medication Guide

(adalimumab-afzb)

MEDICATION GUIDE
ABRILADA™ (AH brill-ah-dah)
(adalimumab-afzb)
injection, for subcutaneous use

Read the Medication Guide that comes with ABRILADA before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your healthcare provider about your medical condition or treatment.

What is the most important information I should know about ABRILADA?
ABRILADA is a medicine that affects your immune system. ABRILADA can lower the ability of your immune system to fight infections. Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi or bacteria that have spread throughout the body. Some people have died from these infections.

•
Your healthcare provider should test you for TB before starting ABRILADA.
•
Your healthcare provider should check you closely for signs and symptoms of TB during treatment with ABRILADA.

You should not start taking ABRILADA if you have any kind of infection unless your healthcare provider says it is okay.
Before starting ABRILADA, tell your healthcare provider if you:

•
think you have an infection or have symptoms of infection such as:
o
fever, sweats, or chills
o
muscle aches
o
cough
o
shortness of breath
o
blood in phlegm
o
warm, red, or painful skin or sores on your body
o
diarrhea or stomach pain
o
burning when you urinate or urinate more often than normal
o
feel very tired
o
weight loss
•
are being treated for an infection.
•
get a lot of infections or have infections that keep coming back.
•
have diabetes.
•
have TB, or have been in close contact with someone with TB.
•
were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure.
•
live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may happen or become more severe if you use ABRILADA. Ask your healthcare provider if you do not know if you have lived in an area where these infections are common.
•
have or have had hepatitis B.
•
use the medicine ORENCIA (abatacept), KINERET (anakinra), RITUXAN (rituximab), IMURAN (azathioprine), or PURINETHOL (6–mercaptopurine, 6-MP).
•
are scheduled to have major surgery

After starting ABRILADA, call your healthcare provider right away if you have an infection, or any sign of an infection.
ABRILADA can make you more likely to get infections or make any infection that you may have worse.
Cancer

•
For children and adults taking tumor necrosis factor (TNF) blockers, including ABRILADA, the chances of getting cancer may increase.
•
There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers.
•
People with rheumatoid arthritis (RA), especially more serious RA, may have a higher chance for getting a kind of cancer called lymphoma.
•
If you use TNF blockers including ABRILADA your chance of getting two types of skin cancer may increase (basal cell cancer and squamous cell cancer of the skin). These types of cancer are generally not life-threatening if treated. Tell your healthcare provider if you have a bump or open sore that does not heal.
•
Some people receiving TNF blockers including ABRILADA developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. Most of these people were male teenagers or young men. Also, most people were being treated for Crohn's disease or ulcerative colitis with another medicine called IMURAN (azathioprine) or PURINETHOL (6-mercaptopurine, 6-MP).

What is ABRILADA?
ABRILADA is a medicine called a tumor necrosis factor (TNF) blocker. ABRILADA is used:

•
To reduce the signs and symptoms of:
o
moderate to severe RA in adults. ABRILADA can be used alone, with methotrexate, or with certain other medicines.
o
moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. ABRILADA can be used alone or with methotrexate.
o
psoriatic arthritis (PsA) in adults. ABRILADA can be used alone or with certain other medicines.
o
ankylosing spondylitis (AS) in adults.
o
moderate to severe hidradenitis suppurativa (HS) in adults.
•
To treat moderate to severe Crohn's disease (CD) in adults and children 6 years of age and older.
•
To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
•
To treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
•
To treat non-infectious intermediate, posterior, and panuveitis in adults.

What should I tell my healthcare provider before taking ABRILADA?
ABRILADA may not be right for you. Before starting ABRILADA, tell your healthcare provider about all of your medical conditions, including if you:

•
have an infection. See "What is the most important information I should know about ABRILADA?"
•
have or have had cancer.
•
have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome.
•
have or had heart failure.
•
have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines while using ABRILADA. Children should be brought up to date with all vaccines before starting ABRILADA.
•
are allergic to ABRILADA or to any of its ingredients. See the end of this Medication Guide for a list of ingredients in ABRILADA.
•
are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you should take ABRILADA while you are pregnant or breastfeeding.
•
have a baby and you were using ABRILADA during your pregnancy. Tell your baby's healthcare provider before your baby receives any vaccines.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you use:

•
ORENCIA (abatacept), KINERET (anakinra), REMICADE (infliximab), ENBREL (etanercept), CIMZIA (certolizumab pegol) or SIMPONI (golimumab), because you should not use ABRILADA while you are also using one of these medicines.
•
RITUXAN (rituximab). Your healthcare provider may not want to give you ABRILADA if you have received RITUXAN (rituximab) recently.
•
IMURAN (azathioprine) or PURINETHOL (6–mercaptopurine, 6-MP).

Keep a list of your medicines with you to show your healthcare provider and pharmacist each time you get a new medicine.

How should I take ABRILADA?

•
ABRILADA is given by an injection under the skin. Your healthcare provider will tell you how often to take an injection of ABRILADA. This is based on your condition to be treated. Do not inject ABRILADA more often than you were prescribed.
•
See the Instructions for Use inside the carton for complete instructions for the right way to prepare and inject ABRILADA.
•
Make sure you have been shown how to inject ABRILADA before you do it yourself. You can call your healthcare provider or 1-800-438-1985 if you have any questions about giving yourself an injection. Someone you know can also help you with your injection after they have been shown how to prepare and inject ABRILADA.
•
Do not try to inject ABRILADA yourself until you are shown the right way to give the injections and read and understand the Instructions for Use. If your healthcare provider decides that you or a caregiver may be able to give your injections of ABRILADA at home, you should receive training on the right way to prepare and inject ABRILADA.
•
Do not miss any doses of ABRILADA unless your healthcare provider says it is okay. If you forget to take ABRILADA, inject a dose as soon as you remember. Then, take your next dose at your regular scheduled time. This will put you back on schedule. In case you are not sure when to inject ABRILADA, call your healthcare provider or pharmacist.
•
If you take more ABRILADA than you were told to take, call your healthcare provider.

What are the possible side effects of ABRILADA?
ABRILADA can cause serious side effects, including:
See "What is the most important information I should know about ABRILADA?"

•
Serious Infections.
Your healthcare provider will examine you for TB and perform a test to see if you have TB. If your healthcare provider feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with ABRILADA and during treatment with ABRILADA. Even if your TB test is negative your healthcare provider should carefully monitor you for TB infections while you are taking ABRILADA. People who had a negative TB skin test before receiving adalimumab products have developed active TB. Tell your healthcare provider if you have any of the following symptoms while taking or after taking ABRILADA:
o
cough that does not go away
o
low grade fever
o
weight loss
o
loss of body fat and muscle (wasting)
•
Hepatitis B infection in people who carry the virus in their blood.
If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus can become active while you use ABRILADA. Your healthcare provider should do blood tests before you start treatment, while you are using ABRILADA, and for several months after you stop treatment with ABRILADA. Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection:
o
muscle aches
o
feel very tired
o
dark urine
o
skin or eyes look yellow
o
little or no appetite
o
vomiting
o
clay-colored bowel movements
o
fever
o
chills
o
stomach discomfort
o
skin rash
•
Allergic reactions. Allergic reactions can happen in people who use ABRILADA. Call your healthcare provider or get medical help right away if you have any of these symptoms of a serious allergic reaction:
o
hives
o
trouble breathing
o
swelling of your face, eyes, lips or mouth
•
Nervous system problems. Signs and symptoms of a nervous system problem include: numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
•
Blood problems. Your body may not make enough of the blood cells that help fight infections or help to stop bleeding. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
•
New heart failure or worsening of heart failure you already have. Call your healthcare provider right away if you get new worsening symptoms of heart failure while taking ABRILADA, including:
o
shortness of breath
o
sudden weight gain
o
swelling of your ankles or feet
•
Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or a rash on your cheeks or arms that gets worse in the sun. Symptoms may improve when you stop ABRILADA.
•
Liver problems. Liver problems can happen in people who use TNF-blocker medicines. These problems can lead to liver failure and death. Call your healthcare provider right away if you have any of these symptoms:
o
feel very tired
o
poor appetite or vomiting
o
skin or eyes look yellow
o
pain on the right side of your stomach (abdomen)
•
Psoriasis. Some people using adalimumab products had new psoriasis or worsening of psoriasis they already had. Tell your healthcare provider if you develop red scaly patches or raised bumps that are filled with pus. Your healthcare provider may decide to stop your treatment with ABRILADA.

Call your healthcare provider or get medical care right away if you develop any of the above symptoms. Your treatment with ABRILADA may be stopped.

The most common side effects of ABRILADA include:

•
injection site reactions: redness, rash, swelling, itching, or bruising. These symptoms usually will go away within a few days. Call your healthcare provider right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse.
•
upper respiratory infections (including sinus infections).
•
headaches.
•
rash.

These are not all of the possible side effects with ABRILADA. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ABRILADA?

•
Store ABRILADA in the refrigerator at 36°F to 46°F (2°C to 8°C). Store ABRILADA in the original carton until use to protect it from light.
•
Do not freeze ABRILADA. Do not use ABRILADA if frozen, even if it has been thawed.
•
Refrigerated ABRILADA may be used until the expiration date printed on the ABRILADA carton, pen or prefilled syringe. Do not use ABRILADA after the expiration date.
•
If needed, for example when you are traveling, you may also store ABRILADA at room temperature up to 86°F (30°C) for up to 30 days. Store ABRILADA in the original carton until use to protect it from light.
•
Throw away ABRILADA if it has been kept at room temperature and not been used within 30 days.
•
Record the date you first remove ABRILADA from the refrigerator in the spaces provided on the ABRILADA pen carton or the prefilled syringe carton.
•
Do not store ABRILADA in extreme heat or cold.
•
The medicine in ABRILADA should be clear and colorless to very light brown. Do not use a pen or prefilled syringe if the liquid is cloudy, discolored, or has flakes or particles in it.
•
Do not drop or crush ABRILADA. The prefilled syringe is glass.

Keep ABRILADA, injection supplies, and all other medicines out of the reach of children.

General information about the safe and effective use of ABRILADA
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use ABRILADA for a condition for which it was not prescribed. Do not give ABRILADA to other people, even if they have the same condition. It may harm them. This Medication Guide summarizes the most important information about ABRILADA. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about ABRILADA that is written for health professionals.

What are the ingredients in ABRILADA?

Active ingredient: adalimumab-afzb
ABRILADA pen 40 mg/0.8 mL, ABRILADA 40 mg/0.8 mL prefilled syringe, ABRILADA 20 mg/0.4 mL prefilled syringe, ABRILADA 10 mg/0.2 mL prefilled syringe, and ABRILADA 40 mg/0.8 mL institutional use vial:

Inactive ingredients: edetate disodium dihydrate, L-histidine, L-histidine hydrochloride monohydrate, L-methionine, polysorbate 80, sucrose, and Water for Injection.

Pfizer

Manufactured by Pfizer Inc.
New York, NY 10001

Distributed by Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001

US License No. 2001

LAB-1351-5.0

For more information go to www.Pfizer.com.

This Medication Guide has been approved by the U.S. Food and Drug Administration.     Revised: 08/2023

17 PATIENT COUNSELING INFORMATION

Advise the patient or caregiver to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).

Infections

Inform patients that ABRILADA may lower the ability of their immune system to fight infections. Instruct patients of the importance of contacting their healthcare provider if they develop any symptoms of infection, including tuberculosis, invasive fungal infections, and reactivation of hepatitis B virus infections [see Warnings and Precautions (5.1, 5.2, 5.4)].

Malignancies

Counsel patients about the risk of malignancies while receiving ABRILADA [see Warnings and Precautions (5.2)].

Hypersensitivity Reactions

Advise patients to seek immediate medical attention if they experience any symptoms of severe hypersensitivity reactions [see Warnings and Precautions (5.3)].

Other Medical Conditions

Advise patients to report any signs of new or worsening medical conditions such as congestive heart failure, neurological disease, autoimmune disorders, or cytopenias. Advise patients to report any symptoms suggestive of a cytopenia such as bruising, bleeding, or persistent fever [see Warnings and Precautions (5.5, 5.6, 5.8, 5.9)].

Instructions on Injection Technique

Inform patients that the first injection is to be performed under the supervision of a qualified healthcare professional. If a patient or caregiver is to administer ABRILADA, instruct them in injection techniques and assess their ability to inject subcutaneously to ensure the proper administration of ABRILADA [see Instructions for Use].

For patients who will use ABRILADA pen, tell them that they:

•
Will only be able to press down the injection button when they are pushing the pen down firmly enough at the injection site.
•
Will hear a click when the injection button is pressed all the way down. The click means the start of the injection.
•
Will know the injection has finished and have received a full dose of medicine when they see the orange bar in the window, 5 seconds after hearing the 2nd click.

Instruct patients to dispose of their used needles and syringes or used pen in a FDA-cleared sharps disposal container immediately after use. Instruct patients not to dispose of loose needles and syringes or pen in their household trash. Instruct patients that if they do not have a FDA-cleared sharps disposal container, they may use a household container that is made of a heavy-duty plastic, can be closed with a tight-fitting and puncture-resistant lid without sharps being able to come out, upright and stable during use, leak-resistant, and properly labeled to warn of hazardous waste inside the container.

Instruct patients that when their sharps disposal container is almost full, they will need to follow their community guidelines for the correct way to dispose of their sharps disposal container. Instruct patients that there may be state or local laws regarding disposal of used needles and syringes. Refer patients to the FDA's website at http://www.fda.gov/safesharpsdisposal for more information about safe sharps disposal, and for specific information about sharps disposal in the state that they live in.

Instruct patients not to dispose of their used sharps disposal container in their household trash unless their community guidelines permit this. Instruct patients not to recycle their used sharps disposal container.

This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com. For Medical Information about ABRILADA, please visit www.pfizermedinfo.com or call 1-800-438-1985.

Find ABRILADA™ medical information:

Find ABRILADA™ medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ABRILADA™ Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Medication Guide

MEDICATION GUIDE
ABRILADA™ (AH brill-ah-dah)
(adalimumab-afzb)
injection, for subcutaneous use

Read the Medication Guide that comes with ABRILADA before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your healthcare provider about your medical condition or treatment.

What is the most important information I should know about ABRILADA?
ABRILADA is a medicine that affects your immune system. ABRILADA can lower the ability of your immune system to fight infections. Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi or bacteria that have spread throughout the body. Some people have died from these infections.

•
Your healthcare provider should test you for TB before starting ABRILADA.
•
Your healthcare provider should check you closely for signs and symptoms of TB during treatment with ABRILADA.

You should not start taking ABRILADA if you have any kind of infection unless your healthcare provider says it is okay.
Before starting ABRILADA, tell your healthcare provider if you:

•
think you have an infection or have symptoms of infection such as:
o
fever, sweats, or chills
o
muscle aches
o
cough
o
shortness of breath
o
blood in phlegm
o
warm, red, or painful skin or sores on your body
o
diarrhea or stomach pain
o
burning when you urinate or urinate more often than normal
o
feel very tired
o
weight loss
•
are being treated for an infection.
•
get a lot of infections or have infections that keep coming back.
•
have diabetes.
•
have TB, or have been in close contact with someone with TB.
•
were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure.
•
live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may happen or become more severe if you use ABRILADA. Ask your healthcare provider if you do not know if you have lived in an area where these infections are common.
•
have or have had hepatitis B.
•
use the medicine ORENCIA (abatacept), KINERET (anakinra), RITUXAN (rituximab), IMURAN (azathioprine), or PURINETHOL (6–mercaptopurine, 6-MP).
•
are scheduled to have major surgery

After starting ABRILADA, call your healthcare provider right away if you have an infection, or any sign of an infection.
ABRILADA can make you more likely to get infections or make any infection that you may have worse.
Cancer

•
For children and adults taking tumor necrosis factor (TNF) blockers, including ABRILADA, the chances of getting cancer may increase.
•
There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers.
•
People with rheumatoid arthritis (RA), especially more serious RA, may have a higher chance for getting a kind of cancer called lymphoma.
•
If you use TNF blockers including ABRILADA your chance of getting two types of skin cancer may increase (basal cell cancer and squamous cell cancer of the skin). These types of cancer are generally not life-threatening if treated. Tell your healthcare provider if you have a bump or open sore that does not heal.
•
Some people receiving TNF blockers including ABRILADA developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. Most of these people were male teenagers or young men. Also, most people were being treated for Crohn's disease or ulcerative colitis with another medicine called IMURAN (azathioprine) or PURINETHOL (6-mercaptopurine, 6-MP).

What is ABRILADA?
ABRILADA is a medicine called a tumor necrosis factor (TNF) blocker. ABRILADA is used:

•
To reduce the signs and symptoms of:
o
moderate to severe RA in adults. ABRILADA can be used alone, with methotrexate, or with certain other medicines.
o
moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. ABRILADA can be used alone or with methotrexate.
o
psoriatic arthritis (PsA) in adults. ABRILADA can be used alone or with certain other medicines.
o
ankylosing spondylitis (AS) in adults.
o
moderate to severe hidradenitis suppurativa (HS) in adults.
•
To treat moderate to severe Crohn's disease (CD) in adults and children 6 years of age and older.
•
To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
•
To treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
•
To treat non-infectious intermediate, posterior, and panuveitis in adults.

What should I tell my healthcare provider before taking ABRILADA?
ABRILADA may not be right for you. Before starting ABRILADA, tell your healthcare provider about all of your medical conditions, including if you:

•
have an infection. See "What is the most important information I should know about ABRILADA?"
•
have or have had cancer.
•
have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome.
•
have or had heart failure.
•
have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines while using ABRILADA. Children should be brought up to date with all vaccines before starting ABRILADA.
•
are allergic to ABRILADA or to any of its ingredients. See the end of this Medication Guide for a list of ingredients in ABRILADA.
•
are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you should take ABRILADA while you are pregnant or breastfeeding.
•
have a baby and you were using ABRILADA during your pregnancy. Tell your baby's healthcare provider before your baby receives any vaccines.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you use:

•
ORENCIA (abatacept), KINERET (anakinra), REMICADE (infliximab), ENBREL (etanercept), CIMZIA (certolizumab pegol) or SIMPONI (golimumab), because you should not use ABRILADA while you are also using one of these medicines.
•
RITUXAN (rituximab). Your healthcare provider may not want to give you ABRILADA if you have received RITUXAN (rituximab) recently.
•
IMURAN (azathioprine) or PURINETHOL (6–mercaptopurine, 6-MP).

Keep a list of your medicines with you to show your healthcare provider and pharmacist each time you get a new medicine.

How should I take ABRILADA?

•
ABRILADA is given by an injection under the skin. Your healthcare provider will tell you how often to take an injection of ABRILADA. This is based on your condition to be treated. Do not inject ABRILADA more often than you were prescribed.
•
See the Instructions for Use inside the carton for complete instructions for the right way to prepare and inject ABRILADA.
•
Make sure you have been shown how to inject ABRILADA before you do it yourself. You can call your healthcare provider or 1-800-438-1985 if you have any questions about giving yourself an injection. Someone you know can also help you with your injection after they have been shown how to prepare and inject ABRILADA.
•
Do not try to inject ABRILADA yourself until you are shown the right way to give the injections and read and understand the Instructions for Use. If your healthcare provider decides that you or a caregiver may be able to give your injections of ABRILADA at home, you should receive training on the right way to prepare and inject ABRILADA.
•
Do not miss any doses of ABRILADA unless your healthcare provider says it is okay. If you forget to take ABRILADA, inject a dose as soon as you remember. Then, take your next dose at your regular scheduled time. This will put you back on schedule. In case you are not sure when to inject ABRILADA, call your healthcare provider or pharmacist.
•
If you take more ABRILADA than you were told to take, call your healthcare provider.

What are the possible side effects of ABRILADA?
ABRILADA can cause serious side effects, including:
See "What is the most important information I should know about ABRILADA?"

•
Serious Infections.
Your healthcare provider will examine you for TB and perform a test to see if you have TB. If your healthcare provider feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with ABRILADA and during treatment with ABRILADA. Even if your TB test is negative your healthcare provider should carefully monitor you for TB infections while you are taking ABRILADA. People who had a negative TB skin test before receiving adalimumab products have developed active TB. Tell your healthcare provider if you have any of the following symptoms while taking or after taking ABRILADA:
o
cough that does not go away
o
low grade fever
o
weight loss
o
loss of body fat and muscle (wasting)
•
Hepatitis B infection in people who carry the virus in their blood.
If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus can become active while you use ABRILADA. Your healthcare provider should do blood tests before you start treatment, while you are using ABRILADA, and for several months after you stop treatment with ABRILADA. Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection:
o
muscle aches
o
feel very tired
o
dark urine
o
skin or eyes look yellow
o
little or no appetite
o
vomiting
o
clay-colored bowel movements
o
fever
o
chills
o
stomach discomfort
o
skin rash
•
Allergic reactions. Allergic reactions can happen in people who use ABRILADA. Call your healthcare provider or get medical help right away if you have any of these symptoms of a serious allergic reaction:
o
hives
o
trouble breathing
o
swelling of your face, eyes, lips or mouth
•
Nervous system problems. Signs and symptoms of a nervous system problem include: numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
•
Blood problems. Your body may not make enough of the blood cells that help fight infections or help to stop bleeding. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
•
New heart failure or worsening of heart failure you already have. Call your healthcare provider right away if you get new worsening symptoms of heart failure while taking ABRILADA, including:
o
shortness of breath
o
sudden weight gain
o
swelling of your ankles or feet
•
Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or a rash on your cheeks or arms that gets worse in the sun. Symptoms may improve when you stop ABRILADA.
•
Liver problems. Liver problems can happen in people who use TNF-blocker medicines. These problems can lead to liver failure and death. Call your healthcare provider right away if you have any of these symptoms:
o
feel very tired
o
poor appetite or vomiting
o
skin or eyes look yellow
o
pain on the right side of your stomach (abdomen)
•
Psoriasis. Some people using adalimumab products had new psoriasis or worsening of psoriasis they already had. Tell your healthcare provider if you develop red scaly patches or raised bumps that are filled with pus. Your healthcare provider may decide to stop your treatment with ABRILADA.

Call your healthcare provider or get medical care right away if you develop any of the above symptoms. Your treatment with ABRILADA may be stopped.

The most common side effects of ABRILADA include:

•
injection site reactions: redness, rash, swelling, itching, or bruising. These symptoms usually will go away within a few days. Call your healthcare provider right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse.
•
upper respiratory infections (including sinus infections).
•
headaches.
•
rash.

These are not all of the possible side effects with ABRILADA. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ABRILADA?

•
Store ABRILADA in the refrigerator at 36°F to 46°F (2°C to 8°C). Store ABRILADA in the original carton until use to protect it from light.
•
Do not freeze ABRILADA. Do not use ABRILADA if frozen, even if it has been thawed.
•
Refrigerated ABRILADA may be used until the expiration date printed on the ABRILADA carton, pen or prefilled syringe. Do not use ABRILADA after the expiration date.
•
If needed, for example when you are traveling, you may also store ABRILADA at room temperature up to 86°F (30°C) for up to 30 days. Store ABRILADA in the original carton until use to protect it from light.
•
Throw away ABRILADA if it has been kept at room temperature and not been used within 30 days.
•
Record the date you first remove ABRILADA from the refrigerator in the spaces provided on the ABRILADA pen carton or the prefilled syringe carton.
•
Do not store ABRILADA in extreme heat or cold.
•
The medicine in ABRILADA should be clear and colorless to very light brown. Do not use a pen or prefilled syringe if the liquid is cloudy, discolored, or has flakes or particles in it.
•
Do not drop or crush ABRILADA. The prefilled syringe is glass.

Keep ABRILADA, injection supplies, and all other medicines out of the reach of children.

General information about the safe and effective use of ABRILADA
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use ABRILADA for a condition for which it was not prescribed. Do not give ABRILADA to other people, even if they have the same condition. It may harm them. This Medication Guide summarizes the most important information about ABRILADA. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about ABRILADA that is written for health professionals.

What are the ingredients in ABRILADA?

Active ingredient: adalimumab-afzb
ABRILADA pen 40 mg/0.8 mL, ABRILADA 40 mg/0.8 mL prefilled syringe, ABRILADA 20 mg/0.4 mL prefilled syringe, ABRILADA 10 mg/0.2 mL prefilled syringe, and ABRILADA 40 mg/0.8 mL institutional use vial:

Inactive ingredients: edetate disodium dihydrate, L-histidine, L-histidine hydrochloride monohydrate, L-methionine, polysorbate 80, sucrose, and Water for Injection.

Pfizer

Manufactured by Pfizer Inc.
New York, NY 10001

Distributed by Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001

US License No. 2001

LAB-1351-5.0

For more information go to www.Pfizer.com.

This Medication Guide has been approved by the U.S. Food and Drug Administration.     Revised: 08/2023

17 PATIENT COUNSELING INFORMATION

Advise the patient or caregiver to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).

Infections

Inform patients that ABRILADA may lower the ability of their immune system to fight infections. Instruct patients of the importance of contacting their healthcare provider if they develop any symptoms of infection, including tuberculosis, invasive fungal infections, and reactivation of hepatitis B virus infections [see Warnings and Precautions (5.1, 5.2, 5.4)].

Malignancies

Counsel patients about the risk of malignancies while receiving ABRILADA [see Warnings and Precautions (5.2)].

Hypersensitivity Reactions

Advise patients to seek immediate medical attention if they experience any symptoms of severe hypersensitivity reactions [see Warnings and Precautions (5.3)].

Other Medical Conditions

Advise patients to report any signs of new or worsening medical conditions such as congestive heart failure, neurological disease, autoimmune disorders, or cytopenias. Advise patients to report any symptoms suggestive of a cytopenia such as bruising, bleeding, or persistent fever [see Warnings and Precautions (5.5, 5.6, 5.8, 5.9)].

Instructions on Injection Technique

Inform patients that the first injection is to be performed under the supervision of a qualified healthcare professional. If a patient or caregiver is to administer ABRILADA, instruct them in injection techniques and assess their ability to inject subcutaneously to ensure the proper administration of ABRILADA [see Instructions for Use].

For patients who will use ABRILADA pen, tell them that they:

•
Will only be able to press down the injection button when they are pushing the pen down firmly enough at the injection site.
•
Will hear a click when the injection button is pressed all the way down. The click means the start of the injection.
•
Will know the injection has finished and have received a full dose of medicine when they see the orange bar in the window, 5 seconds after hearing the 2nd click.

Instruct patients to dispose of their used needles and syringes or used pen in a FDA-cleared sharps disposal container immediately after use. Instruct patients not to dispose of loose needles and syringes or pen in their household trash. Instruct patients that if they do not have a FDA-cleared sharps disposal container, they may use a household container that is made of a heavy-duty plastic, can be closed with a tight-fitting and puncture-resistant lid without sharps being able to come out, upright and stable during use, leak-resistant, and properly labeled to warn of hazardous waste inside the container.

Instruct patients that when their sharps disposal container is almost full, they will need to follow their community guidelines for the correct way to dispose of their sharps disposal container. Instruct patients that there may be state or local laws regarding disposal of used needles and syringes. Refer patients to the FDA's website at http://www.fda.gov/safesharpsdisposal for more information about safe sharps disposal, and for specific information about sharps disposal in the state that they live in.

Instruct patients not to dispose of their used sharps disposal container in their household trash unless their community guidelines permit this. Instruct patients not to recycle their used sharps disposal container.

This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com. For Medical Information about ABRILADA, please visit www.pfizermedinfo.com or call 1-800-438-1985.
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.